Search

everythinglearnresearchcommunity

for

Search:↓

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Follow the latest international guidelines to assess and manage Polycystic Ovary Syndrome effectively.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Skin issues are common and important for diagnosing PCOS.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Classical PCOS types A and B are most common and linked to higher health risks.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Women with PCOS have lower self-esteem and body image satisfaction.